Advisory Committee

Robb Richards, MS, MBA is the corporate director of the Cell Therapy and Transplant program at Penn Medicine, with oversight of both commercial and research work, as well as a focus on expansion into community hospitals within the Penn system. With over 20 years of experience in oncology (including bone marrow transplant and CAR T-cell therapy), oncology analytics, EMR integration, information technology, business management of oncology practices, he has been the lead in overseeing the implementation and operations of CAR T-cell therapy for commercial use.

Richards earned his MS and MBA from St. Joseph’s University in Pennsylvania, specializing in oncology informatics, and his bachelor’s degree from Drexel University.